“Transformational” semaglutide can cut Type 2 diabetes risk by more than half – University of Alabama at Birmingham
W. Timothy Garvey, M.D.New research presented by University of Alabama at Birmingham researchers shows that a 2.4mg dose of the obesity drug semaglutide can reduce the risk of Type 2…